Literature DB >> 3063043

Failure of topically applied antibiotics, added to systemic prophylaxis, to reduce perineal wound infection in abdominoperineal excision of the rectum.

F Moesgaard1, M Lykkegaard Nielsen.   

Abstract

In a prospective, randomized trial, prophylactic use of topical antibiotics in addition to systemic prophylaxis was studied in patients undergoing abdominoperineal amputation of the rectum. All patients received gentamicin 80 mg and metronidazole 500 mg intravenously at induction of anesthesia, followed by the same dose 8 hourly for 48 hours. In accordance with the randomization, half of the patients were additionally given gentamicin 160 mg + metronidazole 400 mg topically into the perineal wound at closure. Perineal wound infection appeared in 19 of the 41 patients who received both systemic and topical prophylaxis, and in 18 of the 38 with only systemic antibiotics. Cell-mediated immunity was preoperatively assessed with a skin test (Multitest) in all but three patients. Impairment of cell-mediated immunity was associated with significantly heightened rate of wound infection, and these patients did not benefit from topical antibiotics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063043

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  3 in total

1.  Antimicrobial prophylaxis in colorectal surgery.

Authors:  A M Glenny; F Song
Journal:  Qual Health Care       Date:  1999-06

Review 2.  Intra-operative wound irrigation to reduce surgical site infections after abdominal surgery: a systematic review and meta-analysis.

Authors:  Tara C Mueller; Martin Loos; Bernhard Haller; André L Mihaljevic; Ulrich Nitsche; Dirk Wilhelm; Helmut Friess; Jörg Kleeff; Franz G Bader
Journal:  Langenbecks Arch Surg       Date:  2015-02-14       Impact factor: 3.445

Review 3.  Local Application of Gentamicin in the Prophylaxis of Perineal Wound Infection After Abdominoperineal Resection: A Systematic Review.

Authors:  G D Musters; J W A Burger; C J Buskens; W A Bemelman; P J Tanis
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.